These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 28388050

  • 1. CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain.
    Rankovic Z.
    J Med Chem; 2017 Jul 27; 60(14):5943-5954. PubMed ID: 28388050
    [Abstract] [Full Text] [Related]

  • 2. CNS drug design: balancing physicochemical properties for optimal brain exposure.
    Rankovic Z.
    J Med Chem; 2015 Mar 26; 58(6):2584-608. PubMed ID: 25494650
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY, Liu H, Summerfield SG, Luscombe CN, Sahi J.
    Mol Pharm; 2016 May 02; 13(5):1540-50. PubMed ID: 27015243
    [Abstract] [Full Text] [Related]

  • 6. Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization.
    Ghose AK, Ott GR, Hudkins RL.
    ACS Chem Neurosci; 2017 Jan 18; 8(1):147-154. PubMed ID: 27741392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Demystifying brain penetration in central nervous system drug discovery. Miniperspective.
    Di L, Rong H, Feng B.
    J Med Chem; 2013 Jan 10; 56(1):2-12. PubMed ID: 23075026
    [Abstract] [Full Text] [Related]

  • 13. A new descriptor via bio-mimetic chromatography and modeling for the blood brain barrier (Part II).
    Kouskoura MG, Piteni AI, Markopoulou CK.
    J Pharm Biomed Anal; 2019 Feb 05; 164():808-817. PubMed ID: 29884296
    [Abstract] [Full Text] [Related]

  • 14. Start small and stay small. Minimizing attrition in the clinic with a focus on CNS therapeutics.
    Nienaber V.
    Curr Top Med Chem; 2009 Feb 05; 9(18):1688-704. PubMed ID: 19929834
    [Abstract] [Full Text] [Related]

  • 15. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.
    Wager TT, Chandrasekaran RY, Hou X, Troutman MD, Verhoest PR, Villalobos A, Will Y.
    ACS Chem Neurosci; 2010 Jun 16; 1(6):420-34. PubMed ID: 22778836
    [Abstract] [Full Text] [Related]

  • 16. Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein.
    Dolghih E, Jacobson MP.
    ACS Chem Neurosci; 2013 Feb 20; 4(2):361-7. PubMed ID: 23421687
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Computational prediction of CNS drug exposure based on a novel in vivo dataset.
    Bergström CA, Charman SA, Nicolazzo JA.
    Pharm Res; 2012 Nov 20; 29(11):3131-42. PubMed ID: 22744815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.